Eevia Health Plc receives a 150 KSEK / 13 KEUR sales order for a Bilberry extract product
Eevia Health Plc (”Eevia” or ”The Company”) has received a 13 KEUR sales order for Bilberry extract from its customer in South-Korea.The direct customer is a prominent South-Korean trading company headquartered in Seoul with a marketing reach across the Asian continent. The sales value to Eevia of this new order is c. 13 500 EUR. The product is a Bilberry extract standardized for anthocyanins. The order is expected to be followed by further repeat orders in the future. For further information, please contact: Stein Ulve, CEO, Eevia Health Plc Email: